Thanks a lot, I only took a brief look at those links, but they look promising. Im still new to the pharmaceutical industry, new to investing in general, the only company I've analyzed, or still analyzing is Pfizer. What Im wondering about investing into pharmaceuticals is how to, as a value investor, value upcoming drugs? For example with Pfizer, Lipitor's patent expires in 2011, how can you compensate for that loss, I mean you can't rely on a new blockbuster drug to be developed, so basically how do you evaluate the ability of a pharmaceutical company's R&D's section?
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. M